📰 Leukemia News
Page 111 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
July 10, 2023
Induced pluripotent stem cells (iPSC), a continuing muse in cell therapy research, could potentially be used to improve flaws associated with conventional CAR T therapy.
July 9, 2023
A partial clinical trial hold has been lifted from cancer drug emavusertib and Curis has selected a dose to use in Phase 2 testing. The small molecule is being developed as a potential treatment for blood cancers.
July 8, 2023
A new research paper was published in Genes & Cancer on June 28, 2023, entitled, "A novel t (5; 17) (q35; q21) associated with t (8; 21) (q22; q22) in a patient with acute myeloid leukemia: case report and review of literature."
July 8, 2023
Physicians Premier Emergency Room hosted a blood drive Friday afternoon, aiming to address summer blood shortages in Bryan and College Station.
July 7, 2023
MyJournals.org - Science - Molecules, Vol. 28, Pages 5253: Combination of an Oxindole Derivative with (−)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells (Molecules)
July 7, 2023
MyJournals.org - Science - IJERPH, Vol. 20, Pages 6314: Leukemia Mortality among Benzene-Exposed Workers in Brazil (2006–2011) (International Journal of Environmental Research and Public Health)
July 5, 2023
The Mass. teenager wished to be in the Army for the day, and Make-A-Wish granted his wish in partnership with the U.S. Army Reserve.
July 1, 2023
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and inflamed accompanied by severe itching and peeling of the skin.
June 30, 2023
On Saturday, CMS will launch the Enhancing Oncology Model, the second major project focused on improving quality and access to cancer care while lowering spending.
June 29, 2023
The European Society for Medical Oncology has released a tool to help hematologists evaluate the magnitude of clinical benefit expected from new blood cancer treatments.